Chemoprevention of Lung Cancer: Too Good to be True?

A new study suggests that a blood-based protein signature may help identify people at risk of lung cancer more accurately than conventional screening criteria alone. The findings are promising because they point toward a future in which lung cancer screening could be better targeted—but they also raise important questions about validation, access, and how such tools should be used in real-world medicine.